Hansa Biopharma
Eva Nilsagård is currently founder and CEO of Nilsagård Consulting AB. She has served as CFO of OptiGroup, Vitrolife and Plastal, Senior Vice President Strategy & Business Development at Volvo Group and held senior positions in finance and business development at Volvo, AstraZeneca and SKF. Eva is a board member and chairman of the Audit Committee of Addlife, Bufab, Irras and Xbrane Biopharma, and board member of SEK (Swedish Export Credit Company). Eva Nilsagård has more than ten years of experience as a mentor for young female managers with high potential.
Eva Nilsagård holds an Executive MBA in Economics and a Bsc in accounting and finance from School of Business, Economics and Law in Gothenburg. Eva is Chairman of Hansa Biopharma’s Audit Committee. Independent of Hansa Biopharma and its senior management. Independent of major shareholders of Hansa Biopharma. She was born in 1964.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Hansa Biopharma
2 followers
Hansa Biopharma is an innovative and rapidly growing biopharmaceutical company that leverage its unique enzyme technology to develop innovative and potentially lifesaving and life altering immunomodulating therapies for rare autoimmune conditions, transplant rejection and cancer.